Targeting drug-tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells.
Song X, Lan Y, Zheng X, Zhu Q, Liao X, Liu K, Zhang W, Peng Q, Zhu Y, Zhao L, Chen X, Shu Y, Yang K, Hu J.
Song X, et al. Among authors: liu k.
MedComm (2020). 2023 Aug 24;4(5):e342. doi: 10.1002/mco2.342. eCollection 2023 Oct.
MedComm (2020). 2023.
PMID: 37638338
Free PMC article.
Review.